US Patent Issued to Eiger Group International on Oct. 27 for "Use of chloroquine compounds for treatment of inflammatory conditions" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,402, issued on Oct. 27, was assigned to Eiger Group International Inc. (Palo Alto, Calif.).

"Use of chloroquine compounds for treatment of inflammatory conditions" was invented by Jeffrey S. Glenn (Palo Alto, Calif.) and Edward A. Pham (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods for use of chloroquine compounds for the treatment of a subject in need thereof. Uses include methods of treating inflammatory conditions. Uses also include methods of treating non-alcoholic steatohepatitis in a subject."

The patent was filed on Aug. 12, 2024, under Application No. 18/800,926.

*For further information, inc...